| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Oct 03, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 42,882 | Oct 07, 2024, 07:55 AM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Oct 03, 2024 | Sale | $54.63 | 14,375 | 785,306 | 28,507 | Oct 07, 2024, 07:55 AM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Jul 03, 2024 | Sale | $44.87 | 14,375 | 645,006 | 28,507 | Jul 05, 2024, 04:30 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Jul 03, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 42,882 | Jul 05, 2024, 04:30 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Jun 24, 2024 | Option Exercise | $16.89 | 9,500 | 160,455 | 37,286 | Jun 25, 2024, 05:03 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Jun 24, 2024 | Sale | $45.73 | 9,500 | 434,435 | 27,786 | Jun 25, 2024, 05:03 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Apr 15, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 42,161 | Apr 17, 2024, 04:36 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Apr 15, 2024 | Sale | $44.47 | 14,375 | 639,256 | 27,786 | Apr 17, 2024, 04:36 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Mar 20, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 38,500 | Mar 22, 2024, 04:52 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Mar 20, 2024 | Sale | $44.06 | 15,089 | 664,763 | 28,500 | Mar 22, 2024, 04:52 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Mar 18, 2024 | Option Exercise | $38.14 | 411 | 15,676 | 28,500 | Mar 20, 2024, 06:36 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Jan 03, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 20,286 | Jan 04, 2024, 04:45 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Jan 03, 2024 | Sale | $35.00 | 14,375 | 503,125 | 5,911 | Jan 04, 2024, 04:45 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Dec 21, 2023 | Option Exercise | $16.89 | 9,583 | 161,857 | 15,494 | Dec 22, 2023, 06:45 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Dec 21, 2023 | Sale | $34.57 | 9,583 | 331,284 | 5,911 | Dec 22, 2023, 06:45 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Development Officer | Apr 03, 2023 | Option Exercise | $15.98 | 4,288 | 68,522 | 12,712 | Apr 05, 2023, 07:12 PM | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Development Officer | Apr 05, 2023 | Sale | $16.15 | 8,212 | 132,624 | 4,500 | Apr 05, 2023, 07:12 PM |
Menu